Svein Olav B.
- Country
- Sweden
- Department
- Department of Surgery
Research Overview
- Phase I/II Evaluation of Perioperative Histamine Dihydrochloride and Low-Dose Aldesleukin in Resectable Pancreatic Cancer Patients
- Neoadjuvant FOLFIRINOX Versus Upfront Surgery in Resectable Pancreatic Head Cancer: A Multicenter, Randomized Phase 2 Trial
- Comparison of Perioperative and Adjuvant mFOLFIRINOX Regimens in Patients with Resectable Non-Metastatic Pancreatic Cancer
Data & Insights
Has run more than one trial at 7 of 57 partner sites.
Specializations
Pancreatic Cancer Treatment
This investigator specializes in advancing therapeutic approaches for pancreatic cancer, with particular emphasis on resectable pancreatic head cancer treatment strategies. Their research encompasses evaluation of neoadjuvant and adjuvant therapeutic protocols.
- Surgical Intervention Protocols
- Neoadjuvant Chemotherapy Applications
- Treatment Optimization Studies
A key focus includes investigating survival outcomes and mortality reduction in pancreatic cancer patients.
Metastatic Disease Management
The investigator conducts research in oligometastatic pancreatic cancer treatment, exploring multimodal approaches combining surgical interventions with systemic treatments.
- Multimodal Surgical Techniques
- Chemotherapy Integration
- Survival Outcome Assessment
Their work evaluates comparative effectiveness of combined surgical-chemotherapeutic approaches versus standard chemotherapy protocols.
Treatment Safety Evaluation
The investigator focuses on comprehensive assessment of therapeutic safety profiles in pancreatic cancer treatments, monitoring and analyzing treatment-related adverse events.
- Adverse Event Monitoring
- Safety Profile Analysis
- Treatment Response Assessment
Their research includes detailed evaluation of therapy-associated complications and patient tolerance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.